All the above drugs inhibited their target efficiently, as demonstrated by the decreased phosphorylation of Akt S473 and P70S6K T389 (Figure 4A and Supplementary Table S2B–S2C), indicating that in PEL cells this pathway is indeed druggable. Here, AKT1 is linked to primary effusion lymphoma.